Prostate Cancer
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care.
January 23, 2025
Men's Attitudes Towards Participation in Organised Prostate Cancer Testing: An Abductive Thematic Analysis.
January 22, 2025
Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic Review.
January 22, 2025
Cancer-specific mortality after radical prostatectomy versus radiotherapy in incidental prostate cancer.
January 22, 2025
« Augmented radiotherapy » in the management of high-risk prostate cancer (PCa): a systematic review.
January 22, 2025
PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ORIOLE trial cohorts.
January 21, 2025
Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer.
January 21, 2025
Impact of Additional Active Treatment for Prostate Cancer on Health-related Quality of Life of Men: Results from the EUPROMS 2.0 1-year Follow-up Survey.
January 20, 2025
Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men.
January 20, 2025
Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review.
January 20, 2025
Evaluating the feasibility of AI-predicted bpMRI image features for predicting prostate cancer aggressiveness: a multi-center study.
January 20, 2025